Chrono Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Chrono Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0476
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Chrono Therapeutics Inc (CTI) is a personalized medicine manufacturer that provides programmable passive transdermal drug delivery products. The company provides smartstop, a programmable smoking cessation therapy that helps people to quit smoking and improve cessation outcomes. Its wearable device offers personalized and transdermal nicotine replacement therapy in combination with real-time behavioral support. CTI provides nicotine replacement therapy which is delivered through the skin without needles or injection. The company also offers re-usable base device and replaceable cartridges. It provides pre-clinical trial, scientific support and clinical research services. The company markets its products across the US. CTI is headquartered in Hayward, California, the US.

Chrono Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Chrono Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Chrono Therapeutics Raises USD0.1 Million in Venture Financing 11
Chrono Therapeutics Raises USD32 Million in Series A Venture Financing 12
Chrono Therapeutics Raises USD0.5 Million in Venture Financing 14
Chrono Therapeutics Inc – Key Competitors 15
Chrono Therapeutics Inc – Key Employees 16
Chrono Therapeutics Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Feb 01, 2018: Chrono Therapeutics Announces Appointment of David Happel as Chief Executive Officer 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chrono Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Chrono Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Chrono Therapeutics Raises USD0.1 Million in Venture Financing 11
Chrono Therapeutics Raises USD32 Million in Series A Venture Financing 12
Chrono Therapeutics Raises USD0.5 Million in Venture Financing 14
Chrono Therapeutics Inc, Key Competitors 15
Chrono Therapeutics Inc, Key Employees 16

List of Figures
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chrono Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Chrono Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Chrono Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ProvInce of Manitoba:企業の戦略的SWOT分析
    ProvInce of Manitoba - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • B. Braun Melsungen AG:企業の戦略・SWOT・財務分析
    B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report Summary B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Diebold Nixdorf Inc (DBD):企業の財務・戦略的SWOT分析
    Diebold Nixdorf Inc (DBD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • iVascular SLU:製品パイプライン分析
    Summary iVascular SLU (iVascular) designs, develops and manufactures advanced medical devices and therapies for the treatment of disorders of the cardiovascular system. It offers portfolio of products in the fields of interventional cardiology, endovascular intervention and interventional neuroradio …
  • Massachusetts Institute of Technology-製薬・医療分野:企業M&A・提携分析
    Summary Massachusetts Institute of Technology (MIT) is a research university that provides contract research and education. The institute offers education in the areas of computer science, biology, aeronautics, mechanical engineering, civil engineering, economics, electrical engineering, literature, …
  • Kresta Holdings Limited (KRS):企業の財務・戦略的SWOT分析
    Kresta Holdings Limited (KRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Ilmarinen Mutual Pension Insurance Co-エネルギー分野:企業M&A・提携分析
    Summary Ilmarinen Mutual Pension Insurance Company (IMPIC) is a financial service provider that offers pension insurance and related services. The company provides services for private customers, which include information on pensions, retiring, pensioner, forms and brochures, pensioner's tax card, a …
  • 908 Devices Inc:医療機器:M&Aディール及び事業提携情報
    Summary 908 Devices Inc (908 Devices) is a manufacturer of handheld chemical detection tools, tiny footprint analyzers and fast separation devices. The company’s product portfolio includes MX908, a second-generation tool that leverages high-pressure mass spectrometry (HPMS); M908 focuses on priority …
  • Velan Inc (VLN):企業の財務・戦略的SWOT分析
    Velan Inc (VLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Universal Display Corp (OLED):企業の財務・戦略的SWOT分析
    Summary Universal Display Corp (UDC) is a clean technology company that conducts research, develops and markets organic light emitting diode, technologies and materials. The company offers PHOLED materials which are used in making OLED displays and lighting panels. It provides technologies such as F …
  • Tennessee Valley Authority:電力:M&Aディール及び事業提携情報
    Summary Tennessee Valley Authority (TVA) is a corporate agency providing electricity for business customers, local power companies and distributors. The agency generates power using diverse sources of energy such as hydro, nuclear, coal, diesel generator and other renewable based power plants. TVA p …
  • Dai Nippon Printing Co Ltd (7912):企業の財務・戦略的SWOT分析
    Dai Nippon Printing Co Ltd (7912) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Thomas Cook (India) Limited:企業の戦略・SWOT・財務情報
    Thomas Cook (India) Limited - Strategy, SWOT and Corporate Finance Report Summary Thomas Cook (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Abeona Therapeutics Inc (ABEO):製薬・医療:M&Aディール及び事業提携情報
    Summary Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is a biopharmaceutical company that develops and delivers gene therapy and plasma-based products for severe and life-threatening rare diseases. The company’s lead programs include ABO-101 and ABO-102 adeno-associ …
  • China Eastern Airlines Corporation Limited:企業の戦略・SWOT・財務分析
    China Eastern Airlines Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China Eastern Airlines Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Drax Group Plc (DRX)-エネルギー分野:企業M&A・提携分析
    Summary Drax Group plc (Drax) is a biomass-fuelled electricity generator, which generates electricity from coal and biomass. It operates across three principal areas of activity, electricity generation; electricity sales to business customers; and compressed wood pellet production. The company opera …
  • Active Motif Inc:医療機器:M&Aディール及び事業提携情報
    Summary Active Motif Inc (Active Motif) is a healthcare company that develops and delivers biological research tools. The company’s products include extracts, antibodies, reporter assays, fluorescent dyes, kits, cell, acid, and tissue extracts, molecules and recombinant proteins, among others. It of …
  • Imperial Oil Limited:企業の戦略・SWOT・財務分析
    Imperial Oil Limited - Strategy, SWOT and Corporate Finance Report Summary Imperial Oil Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):企業の財務・戦略的SWOT分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Integra LifeSciences Holdings Corp (IART):企業の財務・戦略的SWOT分析
    Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆